Envision Healthcare Corporation (NYSE:EVHC) shares hit a new 52-week low during trading on Thursday after Mizuho lowered their price target on the stock from $65.00 to $57.00. Mizuho currently has a neutral rating on the stock. Envision Healthcare Corporation traded as low as $52.00 and last traded at $51.83, with a volume of 1,787,525 shares. The stock had previously closed at $54.35.
Several other research analysts also recently commented on EVHC. BidaskClub downgraded Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $72.00 price target on shares of Envision Healthcare Corporation in a report on Monday, June 5th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Envision Healthcare Corporation in a report on Monday, July 24th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $71.00 price target (down previously from $75.00) on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd. Finally, Zacks Investment Research cut Envision Healthcare Corporation from a “buy” rating to a “hold” rating in a report on Friday, July 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Envision Healthcare Corporation currently has an average rating of “Buy” and a consensus price target of $71.56.
In related news, insider Robert Jon Coward sold 1,500 shares of the firm’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the transaction, the insider now directly owns 97,863 shares of the company’s stock, valued at approximately $6,135,031.47. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.10% of the company’s stock.
A number of institutional investors have recently made changes to their positions in EVHC. Commonwealth Bank of Australia boosted its position in shares of Envision Healthcare Corporation by 24.3% in the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after buying an additional 410 shares during the period. Livforsakringsbolaget Skandia Omsesidigt bought a new position in shares of Envision Healthcare Corporation during the first quarter worth approximately $135,000. Korea Investment CORP bought a new position in shares of Envision Healthcare Corporation during the first quarter worth approximately $141,000. Ameritas Investment Partners Inc. bought a new position in shares of Envision Healthcare Corporation during the first quarter worth approximately $172,000. Finally, First Interstate Bank bought a new position in shares of Envision Healthcare Corporation during the first quarter worth approximately $184,000. 64.75% of the stock is currently owned by institutional investors and hedge funds.
The company’s market cap is $6.04 billion. The company has a 50-day moving average price of $59.68 and a 200 day moving average price of $61.26.
Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.96 billion. During the same period in the prior year, the business posted $0.34 earnings per share. The company’s revenue for the quarter was up 156.7% on a year-over-year basis. Equities analysts predict that Envision Healthcare Corporation will post $1.40 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This article was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/2800012/envision-healthcare-corporation-evhc-hits-new-52-week-low-following-analyst-downgrade.html.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.